• 45 Citations
  • 2 h-Index
20142019
If you made any changes in Pure these will be visible here soon.

Research Output 2014 2019

  • 45 Citations
  • 2 h-Index
  • 6 Article
  • 1 Meeting Abstract
  • 1 PhD Thesis - Research UT, graduation UT
2019
4 Downloads (Pure)

Predictors of biologic-free disease control in patients with rheumatoid arthritis after stopping tumor necrosis factor inhibitor treatment

Ghiti Moghadam, M., Lamers-Karnebeek, F. B. G., Vonkeman, H. E., ten Klooster, P. M., Tekstra, J., van Schaeybroeck, B., Klaasen, R., van Onna, M., Bernelot Moens, H. J., Visser, H., Schilder, A. M., Kok, M. R., Landewé, R. B. M., van Riel, P. L. C. M., van de Laar, M. A. F. J. & Jansen, T. L., 13 Jun 2019, In : BMC Rheumatology. 3, 3, p. 1-8 8 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access
File
Biological Products
Rheumatoid Arthritis
Tumor Necrosis Factor-alpha
Therapeutics
Biomarkers
90 Downloads (Pure)

Stopping tumor necrosis factor inhibitors in well controlled rheumatoid arthritis patients: the poet study

Ghiti Moghadam, M., 22 Mar 2019, Enschede: University of Twente. 190 p.

Research output: ThesisPhD Thesis - Research UT, graduation UTAcademic

Open Access
File
2018
2 Citations (Scopus)
5 Downloads (Pure)

An economic evaluation of stopping versus continuing TNF-inhibitor treatment in rheumatoid arthritis patients in remission or low disease activity: results from the POET randomized trial

Tran-Duy, A., Ghiti Moghadam, M., Oude Voshaar, M. A. H., Vonkeman, H. E., Boonen, A., Philip, C., McColl, G., ten Klooster, P. M., Zijlstra, T., Lems, W. F., Riyazi, N., Griep, E. N., Hazes, M., Landewe, R., Bernelot Moens, H. J., van Riel, P. L. C. M., van de Laar, M. A. F. J. & Jansen, T. L., Oct 2018, In : Arthritis & rheumatology. 70, 10, p. 1557-1564 8 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access
File
Quality-Adjusted Life Years
Cost-Benefit Analysis
Rheumatoid Arthritis
Costs and Cost Analysis
Tumor Necrosis Factor-alpha
39 Downloads (Pure)

Impact of Stopping Tumor Necrosis Factor inhibitors on Rheumatoid Arthritis Patients' Burden of Disease

Ghiti Moghadam, M., ten Klooster, P. M., Vonkeman, H. E., Kneepkens, E. L., Klaasen, R., Stolk, J. N., Tchetverikov, I., Vreugdenhil, S. A., van Woerkom, J. M., Goekoop-Ruiterman, Y. P. M., Landewé, R. B. M., van Riel, P. L. C. M., van de Laar, M. A. F. J. & Jansen, T. L., 1 Apr 2018, In : Arthritis care & research. 70, 4, p. 516-524 9 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access
File
Rheumatoid Arthritis
Tumor Necrosis Factor-alpha
Health Status
Fatigue
Mental Health
3 Citations (Scopus)
10 Downloads (Pure)

Multi-biomarker disease activity score as a predictor of disease relapse in patients with rheumatoid arthritis stopping TNF inhibitor treatment

Moghadam, M. G., Lamers-Karnebeek, F. B. G., Vonkeman, H. E., ten Klooster, P. M., Tekstra, J., Schilder, A. M., Visser, H., Sasso, E. H., Chernoff, D., Lems, W. F., van Schaardenburg, D-J., Landewe, R., Bernelot Moens, H. J., Radstake, T. R. D. J., van Riel, P. L. C. M., van de Laar, M. A. F. J. & Jansen, T. L., 23 May 2018, In : PLoS ONE. 13, 5, e0192425.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access
File
rheumatoid arthritis
relapse
Biomarkers
biomarkers
Rheumatoid Arthritis
2017
1 Citation (Scopus)

Measuring Disease Exacerbation and Flares in Rheumatoid Arthritis: Comparison of Commonly Used Disease Activity Indices and Individual Measures

Oude Voshaar, M. A. H., Ghiti Moghadam, M., Vonkeman, H. E., ten Klooster, P. M., van Schaardenburg, D., Tekstra, J., Visser, H., van de Laar, M. A. F. J. & Jansen, T. L., 15 May 2017, In : Journal of rheumatology. 44, 8, p. 1118-1124

Research output: Contribution to journalArticleAcademicpeer-review

Disease Progression
Rheumatoid Arthritis
Prostaglandins A
Pain
Aptitude
2016
39 Citations (Scopus)
52 Downloads (Pure)

Stopping Tumor Necrosis Factor Inhibitor Treatment in Patients With Established Rheumatoid Arthritis in Remission or With Stable Low Disease Activity: A Pragmatic Multicenter, Open‐Label Randomized Controlled Trial

Ghiti Moghadam, M., Vonkeman, H. E., ten Klooster, P. M., Tekstra, J., van Schaardenburg, D-J., Starmans-Kool, M., Brouwer, E., Bos, R., Lems, W. F., Colin, E. M., Allaart, C. F., Meek, I. L., Landewe, R., Bernelot Moens, H. J., van Riel, P. L. C. M., van de Laar, M. A. F. J. & Jansen, T. L., 11 Feb 2016, In : Arthritis & rheumatology. 68, 8, p. 1810-1817

Research output: Contribution to journalArticleAcademicpeer-review

Open Access
File
Rheumatoid Arthritis
Randomized Controlled Trials
Tumor Necrosis Factor-alpha
Joints
Therapeutics
2014

Randomized trial of stopping TNF-inhibitors in rheumatoid arthrisis: patients with stable low disease activity in the Netherlands

Vonkeman, H. E., Moghadam, M. G., van de Laar, M. A. F. J., ten Klooster, P. M., Jansen, T. & van Riel, P., 2014, In : Arthritis & rheumatology. 66, 12, p. 3537-3537 1 p., L19.

Research output: Contribution to journalMeeting AbstractOther research output

Netherlands
Rheumatoid Arthritis
Antirheumatic Agents
Disclosure
Survival Analysis